Representative Matter

Related Content

Practices
Industries
Professionals

Fortune 500 pharmaceutical company

Representation of a Fortune 500 pharmaceutical company in connection with its acquisition of a developer and manufacturer of catheter systems, pursuant to a reverse triangular merger. Total consideration was approximately $120 million.